Search results
Q1 2024 Viatris Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoWe have an incredibly talented team. And we have clear plans to deliver on our key R&D objectives to support Viatris' overall growth. Now I will turn the call over to Doretta to work through ...
Q1 2024 Charles River Laboratories International Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoBiotechs are beginning to move back into favor in the capital markets and will lead the way while large pharma has consistently adapted to scientific advancements, the regulatory ...
Q4 2024 STERIS plc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoJack, if you give the instructions, we can open for Q&A. Question and Answer Session Operator (Operator Instructions) And the first question will come from Patrick Wood with Morgan Stanley.
Q1 2024 Clarivate PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoWe will deliver tailored solutions directly to our core customers across pharma, biotech and medical technology. While a large component of our R&D spend to target towards ...
Q1 2024 International Flavors & Fragrances Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoI think we are now getting the clarity we need and have taken some decisive steps in the first quarter to help us start to realize more of our potential. We recently rightsized ...
Q1 2024 Halozyme Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoAnd secondly, our partner Vive initiated another Phase one study for v. eight four five two four one eight four, which is an integrase inhibitor with enhanced the performance of our Wave two ...
Q1 2024 Varonis Systems Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoAndrew Nowinski; Analyst; Wells Fargo Securities, LLC Presentation Operator Greetings, and welcome to bet on this system Inc. First Quarter... Perz Thank you, operator. Good ...
TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the stock. TherapeuticsMD ...
Q1 2024 National Cinemedia Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoThe positive impact our advertising has on brands demonstrates where they continue to turn to NCM. One example is a leading...opportunities to U.S. brands, agencies, media companies and other ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoEndo, Inc. announced today that its Endo Injectable Solutions business unit launched its enhanced ready-to-use product line and platform, TruDelivery®, underscoring the company's commitment ...
